Morgan Stanley (MS)
203.96
+2.35 (1.17%)
NYSE· Last Trade: May 28th, 3:23 PM EDT
Detailed Quote
| Previous Close | 201.61 |
|---|---|
| Open | 199.92 |
| Bid | 203.94 |
| Ask | 203.98 |
| Day's Range | 199.68 - 204.38 |
| 52 Week Range | 126.35 - 203.92 |
| Volume | 3,629,308 |
| Market Cap | 372.14B |
| PE Ratio (TTM) | 19.98 |
| EPS (TTM) | 10.2 |
| Dividend & Yield | 4.000 (1.96%) |
| 1 Month Average Volume | 5,243,145 |
Chart
About Morgan Stanley (MS)
Morgan Stanley is a leading global financial services firm that provides a wide range of services in investment banking, securities, wealth management, and investment management. Catering to a diverse clientele that includes corporations, governments, and individuals, Morgan Stanley offers expert advisory and financing services, helping clients navigate complex financial markets and achieve their financial objectives. The firm is known for its strategic insights, innovative solutions, and commitment to delivering exceptional service, positioning itself as a trusted partner in the world of finance. Read More
News & Press Releases
Reservoir (RSVR) Q4 2026 Earnings Transcript
Via The Motley Fool · May 28, 2026
Banks can see their margins improve if the Fed begins raising rates. But the best play is to concentrate on the big banks instead of the broader financial services sector.
Via The Motley Fool · May 28, 2026
June S&P 500 E-Mini futures (ESM26) are down -0.26%, and June Nasdaq 100 E-Mini futures (NQM26) are down -0.54% this morning, pointing to a lower open on Wall Street as oil prices and bond yields rose after fresh attacks in the Middle East cast doubt...
Via Barchart.com · May 28, 2026
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...
Via StockStory · May 28, 2026
On May 27, 2026, Micron’s latest surge kept AI chips in focus even as broader U.S. benchmarks barely budged.
Via The Motley Fool · May 27, 2026
The emerging digital advertising giant received a boost from a Wall Street analyst today.
Via The Motley Fool · May 27, 2026
Ted Pick, Chairman and Chief Executive Officer of Morgan Stanley, will speak at the Annual Morgan Stanley U.S. Financials Conference on June 9, 2026, at 12:05 p.m. (ET).
By Morgan Stanley · Via Business Wire · May 27, 2026
Piper Sandler stock delivered record revenue growth and rising dividends, but analysts remain cautious about cyclical investment banking risks.
Via MarketBeat · May 27, 2026
AppLovin stock rallied more than 10% Wednesday, with shares likely helped by positive analyst commentary from Morgan Stanley.
Via Investor's Business Daily · May 27, 2026
BofA sees Apple (AAPL) hitting $380 on its agentic AI thesis. But skeptics from CFRA to Morgan Stanley and prediction market traders aren't convinced.
Via Benzinga · May 27, 2026
With tech 'on a tear,' Morgan Stanley's Kathleen Entwistle says to diversify into SLB, gold, and real assets to hedge against inflation.
Via Benzinga · May 27, 2026
Everest Group has underperformed the broader market over the past year, and analysts remain moderately optimistic about the stock’s prospects.
Via Barchart.com · May 27, 2026
Broadridge Financial has considerably underperformed the broader market over the past 52 weeks, yet Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
Via Barchart.com · May 26, 2026
It provided key details of a closely watched upcoming IPO.
Via The Motley Fool · May 26, 2026
Tesla’s fully self-driving ambitions could unlock a new phase of long-term value creation as advances in autonomous technology, robotaxis, and AI-driven mobility reshape the company’s growth outlook.
Via Barchart.com · May 26, 2026
It's good news all around for Marvell stock on Tuesday.
Via The Motley Fool · May 26, 2026
Even though Corpay has lagged behind the SPX over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.
Via Barchart.com · May 26, 2026
West Pharmaceutical Services has considerably outperformed the broader market over the past 52 weeks, and Wall Street analysts maintain a highly optimistic outlook about the stock’s prospects.
Via Barchart.com · May 26, 2026
Although IDEXX Laboratories has lagged the broader market over the past year, Wall Street analysts remain fairly bullish about the company’s long-term growth prospects.
Via Barchart.com · May 26, 2026
Arthur J. Gallagher has underperformed the broader market over the past year, yet analysts remain moderately optimistic about the stock’s prospects.
Via Barchart.com · May 26, 2026
Charles River Laboratories has underperformed the S&P 500 over the past 52 weeks, yet Wall Street analysts maintain a highly optimistic outlook about the stock’s prospects.
Via Barchart.com · May 26, 2026
The efficacy of Eli Lilly's new, still-in-development GLP-1 drug is gaining attention, but don't forget its older GLP-1 drugs just yet.
Via The Motley Fool · May 25, 2026
As Paychex has underperformed relative to the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.
Via Barchart.com · May 25, 2026
While CMS Energy has lagged behind the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
Via Barchart.com · May 25, 2026
Despite Expand Energy’s underperformance compared to the broader market over the past year, Wall Street analysts remain very bullish in the company’s long-term growth trajectory.
Via Barchart.com · May 25, 2026